We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

35 hedge funds and large institutions have $311K invested in Envoy Medical Warrant in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less capital invested

Capital invested by funds: $319K → $311K (-$7.7K)

1.6% less ownership

Funds ownership: 42.12%40.52% (-1.6%)

3% less funds holding

Funds holding: 3635 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
5
Closed
3
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change

COCHW Hedge Fund Activity: Q4 2025 in Review

35 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q4 2025, worth a combined $311K — down 2.4% from $319K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of COCHW and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.

The largest buyer was Aristeia Capital, adding an estimated $3.86K. The largest seller was Clear Street, cutting an estimated $6.04K.

  • 35 institutional investors held Envoy Medical Warrant (COCHW) as of Q4 2025, down from 36 in Q3 2025.
  • Funds reported $311K of Envoy Medical Warrant stock for Q4 2025, down 2.4% quarter-over-quarter.
  • 2 funds opened new Envoy Medical Warrant positions in Q4 2025 and 3 closed out, a net change of -1 holder.
  • The largest Envoy Medical Warrant buyer in Q4 2025 was Aristeia Capital, an estimated $3.86K added.
  • The largest Envoy Medical Warrant seller in Q4 2025 was Clear Street, an estimated $6.04K sold.

Based on aggregated 13F filings for Q4 2025.